Filing Details
- Accession Number:
- 0001421563-13-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-14 17:14:56
- Reporting Period:
- 2013-06-13
- Filing Date:
- 2013-06-14
- Accepted Time:
- 2013-06-14 17:14:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
899923 | Myriad Genetics Inc | MYGN | In Vitro & In Vivo Diagnostic Substances (2835) | 870494517 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1421563 | Gardner Robert Harrison | 320 Wakara Way Salt Lake City UT 84108 | Chief Information Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-06-13 | 17,498 | $16.53 | 20,593 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-06-13 | 17,498 | $35.09 | 3,095 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-06-13 | 14,000 | $19.47 | 17,095 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-06-13 | 14,000 | $37.52 | 3,095 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-06-13 | 17,498 | $0.00 | 17,498 | $16.53 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-06-13 | 14,000 | $0.00 | 14,000 | $19.47 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
17,500 | 2020-09-15 | No | 4 | M | Direct | |
42,000 | 2021-09-13 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.